MAIA Biotechnology, Inc. (MAIA) Stock price, Description, News & Info

#Thinksabio latest news

$MAIA – MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer